Using Sanger sequencing, they analyzed TERT promoter hotspot mutations, observing that approximately 60% of eHCC cases harbored TERT mutations, while nearly 65% of classical HCC tumors had TERT promoter mutations. The gene discussed is TERT; the disease is hepatocellular carcinoma.